Christopher A. Kroeger sold $1.4M of MapLight Therapeutics (MPLT)

Executed May 4, disclosed May 6, 2 days later.

Value, as filed

$1.4M

47,808 sh across 5 lots

Executed

May 4

the trade date, as filed

Disclosed

May 6

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Christopher A. Kroeger Chief Executive Officer profile →

Christopher A. Kroeger (Chief Executive Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in MapLight Therapeutics, Inc. (MPLT). The largest single filing was $5.4M of MPLT (147,457 sh across 5 lots, as filed), executed Jul 15.

The name

MPLT

MapLight Therapeutics, Inc. MPLT · Healthcare · 32 filings in 24 months ticker →

Healthcare · MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christopher A. Kroeger in MPLT

MPLTSALE MapLight Therapeutics, Inc. $595K
73,691 sh × $8.08
Exec Oct 15
Filed Oct 16 · 5:00 PM ET MPLTSALE MapLight Therapeutics, Inc. $5.4M
147,457 sh across 5 lots
Exec Jul 15
Filed Jul 17 · 9:46 PM ET MPLTSALE MapLight Therapeutics, Inc. $3.2M
118,037 sh × $27.19
Exec May 18
Filed May 18 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. $1.8M
62,485 sh across 5 lots
Exec May 7
Filed May 11 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. $454K
16,710 sh across 2 lots
Exec Apr 15
Filed Apr 17 · 5:30 PM ET